These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21219581)

  • 1. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.
    Egawa H; Ueda Y; Ichida T; Teramukai S; Nakanuma Y; Onishi S; Tsubouchi H
    Am J Transplant; 2011 Mar; 11(3):518-27. PubMed ID: 21219581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience.
    Egawa H; Taira K; Teramukai S; Haga H; Ueda Y; Yonezawa A; Masuda S; Tsuji H; Ashihara E; Takada Y; Uemoto S
    Dig Dis Sci; 2009 Jun; 54(6):1347-54. PubMed ID: 19267192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R; Mantry P; Sharma R; Maloo MK; Safadjou S; Qi Y; Jain A; Maliakkal B; Ryan C; Orloff M
    J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
    Heinemann M; Liwinski T; Adam R; Berenguer M; Mirza D; Malek-Hosseini SA; Heneghan MA; Lodge P; Pratschke J; Boudjema K; Paul A; Zieniewicz K; Fronek J; Mehrabi A; Acarli K; Tokat Y; Coker A; Yilmaz S; Karam V; Duvoux C; Lohse AW; Schramm C;
    Am J Transplant; 2022 Feb; 22(2):626-633. PubMed ID: 34605157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Matsui Y; Togashi J; Makuuchi M
    Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.
    Choudhary NS; Saigal S; Thummala S; Saraf N; Rastogi A; Bhangui P; Srinivasan T; Yadav SK; Nundy S; Soin AS
    J Clin Exp Hepatol; 2020; 10(5):442-447. PubMed ID: 33029052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA
    Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
    Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
    Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation in children with cholestatic liver disease: a single-center experience.
    Mizuta K; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N; Egami S; Hishikawa S; Hyodo M; Sakuma Y; Fujiwara T; Kawarasaki H; Yasuda Y
    Transplant Proc; 2012 Mar; 44(2):469-72. PubMed ID: 22410047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft failure from severe recurrent primary sclerosing cholangitis following orthotopic liver transplantation.
    Gopal DV; Corless CL; Rabkin JM; Olyaei AJ; Rosen HR
    J Clin Gastroenterol; 2003 Oct; 37(4):344-7. PubMed ID: 14506394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.
    Henson JB; Patel YA; King LY; Zheng J; Chow SC; Muir AJ
    Liver Transpl; 2017 Jun; 23(6):769-780. PubMed ID: 28027592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
    Hildebrand T; Pannicke N; Dechene A; Gotthardt DN; Kirchner G; Reiter FP; Sterneck M; Herzer K; Lenzen H; Rupp C; Barg-Hock H; de Leuw P; Teufel A; Zimmer V; Lammert F; Sarrazin C; Spengler U; Rust C; Manns MP; Strassburg CP; Schramm C; Weismüller TJ;
    Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases.
    Aravinthan AD; Doyle AC; Issachar A; Dib M; Peretz D; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Greig PD; Grant DR; Selzner N; Lilly LB; Renner EL
    Am J Transplant; 2016 Dec; 16(12):3512-3521. PubMed ID: 27088432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of cholestatic liver disease after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Togashi J; Matsui Y; Yamashiki N; Kokudo N; Makuuchi M
    World J Gastroenterol; 2008 Sep; 14(33):5105-9. PubMed ID: 18777585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.